142 Established and emerging less-invasive biomarkers and technologies for lung cancer diagnostic screening: Puerto Rican context
Yamixa Delgado, Keisy Rodriguez-Villafañe, Juan E Figueroa, Edwin Figueroa, Daraishka Pérez · 2026
Read 142 Established and emerging less-invasive biomarkers and technologies for lung cancer diagnostic screening: Puerto Rican context by Yamixa Delgado, Keisy Rodriguez-Villafañe, Juan E Figueroa, Edwin Figueroa, Daraishka Pérez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13172961.txt.
Description
Yamixa Delgado and co-authors review lung cancer screening in Puerto Rico in a 2026 paper. Lung cancer kills many patients because it is usually found late. The standard screen, a low-dose CT scan, cuts deaths but is hard to access on the island and gives false alarms.
The review weighs gentler options: blood protein markers, breath tests, and liquid biopsies that read tumour DNA from blood. Each shows promise yet suffers from uneven accuracy so far. The team also describes an ongoing study that will measure these markers in newly diagnosed patients against healthy controls. Their goal is a combined, non-invasive panel that fits local limits on cost and access, and narrows the island's care gaps.
Catalog record
| CREATOR | Yamixa Delgado, Keisy Rodriguez-Villafañe, Juan E Figueroa, Edwin Figueroa, Daraishka Pérez |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |